2022
Trends in the Cost and Utilization of Omalizumab in the Medicare Population: 2013-2017.
Cheraghlou S, Ugwu N, Yu B, Cohen JM. Trends in the Cost and Utilization of Omalizumab in the Medicare Population: 2013-2017. The Yale Journal Of Biology And Medicine 2022, 95: 207-212. PMID: 35782473, PMCID: PMC9235260.Peer-Reviewed Original Research
2021
Trends in office visits and treatment for urticaria in children in the United States, 1998‐2016
Ugwu N, Cheraghlou S, Antaya RJ, Feng H, Cohen JM. Trends in office visits and treatment for urticaria in children in the United States, 1998‐2016. Pediatric Dermatology 2021, 38: 1162-1168. PMID: 34339077, DOI: 10.1111/pde.14726.Peer-Reviewed Original ResearchConceptsPediatric populationH1-antihistaminesTopical corticosteroidsFemale patientsNational Ambulatory Medical Care SurveyMost visitsAmbulatory Medical Care SurveyNon-corticosteroid therapySlight male predominanceFemale pediatric patientsMale predominancePediatric patientsTreatment guidelinesWhite patientsOffice visitsOutpatient recordsCare SurveyTreatment trendsUrticariaCommon conditionPatientsCalendar year 1998Age 18PediatriciansAntihistaminesCharacterization of outpatient visits and treatments for urticaria in the United States adult population between 1998 and 2016
Ugwu N, Cheraghlou S, Feng H, Cohen JM. Characterization of outpatient visits and treatments for urticaria in the United States adult population between 1998 and 2016. Journal Of The American Academy Of Dermatology 2021, 86: 936-938. PMID: 33774091, DOI: 10.1016/j.jaad.2021.03.067.Peer-Reviewed Original Research